Company Dian Diagnostics Group Co.,Ltd.

Equities

300244

CNE1000015N1

Healthcare Facilities & Services

Analysts' Consensus

Business Summary

Sales per Business

Sales per region

Managers

Members of the board

Share class

Shareholders

Holdings

Company contact information

Sector

Sales per Business

Ratings for Dian Diagnostics Group Co.,Ltd.

EPS Revisions

Quarterly earnings - Rate of surprise

Sector Medical & Diagnostic Laboratories

End-of-day quote Shenzhen S.E. Other stock markets 06:00:00 2024-04-23 pm EDT			5-day change	1st Jan Change
14.15 ^CNY	-1.74%		-4.07%	-40.57%

Apr. 19	Dian Diagnostics Group Co.,Ltd. Reports Earnings Results for the Full Year Ended December 31, 2023	CI
Feb. 06	Dian Diagnostics Group Co.,Ltd. announces an Equity Buyback for CNY 200 million worth of its shares.	CI

Dean Diagnostic Technology Group Co., Ltd. is a company providing integrated solutions for medical diagnosis. The Company's main business involves inspection services, product services, health management, judicial expertise, contract research organization (CRO), cold chain logistics and other fields. The Company's business is mainly oriented to medical and health institutions at all levels, such as various general and specialized hospitals, community health service centers, township (town) health centers, physical examination centers, disease prevention and control centers, etc. The Company's products include Atomic Bomb in the field of liquid phase mass spectrometry, Hydrogen Bomb in the field of nucleic acid mass spectrometry, and Man-Made Satellite in the field of pathological diagnosis products and molecular diagnosis products, and others.

Number of employees: 10,843

CNY in Million	2022	Weight	2023	Weight	Delta
Commercial 67.8 %	9,938	49.0 %	9,085	67.8 %	-8.58%
Service 36.2 %	12,234	60.3 %	4,859	36.2 %	-60.28%
Internal Association Elimination -4.0 %	-1,889	-9.3 %	-535	-4.0 %	-71.66%

CNY in Million	2022	Weight	2023	Weight	Delta
China 100.0 %	20,282	100.0 %	13,408	100.0 %	-33.89%

Managers	Title	Age	Since
Hai Bin Chen FOU	Founder	55	95-12-31
De Kang Zhao DFI	Director of Finance/CFO	56	23-08-28
Bai Xìng Huang BRD	Director/Board Member	68	19-05-21
Yang Liu BRD	Director/Board Member	43	04-06-30
Li Jun Shen BRD	Director/Board Member	55	17-07-20
Shi Shi Chen BRD	Director/Board Member	47	13-12-08
San Hui Guo BRD	Director/Board Member	49	19-01-20
Tang Jiang BRD	Director/Board Member	65	15-01-29
Di Sheng Zhu IRC	Investor Relations Contact	41	19-06-26
Jun Tao IRC	Investor Relations Contact	43	08-03-31

Members of the board	Title	Age	Since
Guo Qi Ding BRD	Director/Board Member	55	17-07-16
Hai Bin Chen FOU	Founder	55	95-12-31
Tang Jiang BRD	Director/Board Member	65	15-01-29
San Hui Guo BRD	Director/Board Member	49	19-01-20
Shi Shi Chen BRD	Director/Board Member	47	13-12-08
Xiu Li Cheng CHM	Chairman	49	12-04-30
Wei Ru Chen BRD	Director/Board Member	54	17-07-16
Li Jun Shen BRD	Director/Board Member	55	17-07-20
Tian Tian Li BRD	Director/Board Member	49	20-09-29
Bai Xìng Huang BRD	Director/Board Member	68	19-05-21

	Vote	Quantity	Free-Float	Company-owned shares	Total Float
Stock A	1	629,187,936	219,678,559 ( 34.91 %)	2,289,900 ( 0.3639 %)	34.91 %

Name	Equities	%	Valuation
Hai Bin Chen 11.39 %	51,746,123	11.39 %	125 M ¥
China Huarong Asset Management Co., Ltd. (Invt Port) 5.030 %	22,844,726	5.030 %	55 M ¥
UBS SDIC Fund Management Co., Ltd. 3.117 %	14,155,250	3.117 %	34 M ¥
Hwabao WP Fund Management Co., Ltd. 2.889 %	13,120,166	2.889 %	32 M ¥
Jia Fu Zhong 2.312 %	10,499,953	2.312 %	25 M ¥
National Social Insurance Fund Portfolio 418 2.299 %	10,443,700	2.299 %	25 M ¥
Yinhua Fund Management Co., Ltd. 1.941 %	8,817,128	1.941 %	21 M ¥
Fullgoal Fund Management Co., Ltd. 1.390 %	6,311,558	1.390 %	15 M ¥
Essence Fund Co., Ltd. 1.064 %	4,830,504	1.064 %	12 M ¥
China Southern Asset Management Co., Ltd. 0.8923 %	4,052,915	0.8923 %	10 M ¥

Name	Equities	%	Valuation
Hai Bin Chen 90.33 %	123,329,200	90.33 %	298 M ¥

Name	Equities	%	Valuation
DIAN DIAGNOSTICS GROUP CO.,LTD. 0.02%	103,800	0.02%	251,047 $

Dian Diagnostics Group Co. Ltd.

5/F, Building 2 329, Jinpeng Street, Sandun Town

310030, Hangzhou

+86 571 5808 5608

http://www.dazd.cn

address Dian Diagnostics Group Co.,Ltd.(300244)

Trading Rating

Investor Rating

ESG Refinitiv

C+

More Ratings

Sell

Buy

Mean consensus

BUY

Number of Analysts

Last Close Price

14.15 CNY

Average target price

27.81 CNY

Spread / Average Target

+96.54%

Consensus

Estimates Revisions

Company calendar

Healthcare

Healthcare Services

Healthcare Providers & Services

Healthcare Facilities & Services

Medical & Diagnostic Laboratories

	1st Jan change	Capi.
DIAN DIAGNOSTICS GROUP CO.,LTD.	-40.57%	1.23B
SONIC HEALTHCARE LIMITED	-16.65%	8.36B
RADNET, INC.	+39.98%	3.6B
GUANGZHOU KINGMED DIAGNOSTICS GROUP CO., LTD.	-32.00%	2.87B
SYNLAB AG	-7.71%	2.47B
DR. LAL PATHLABS LIMITED	-9.65%	2.24B
NEOGENOMICS, INC.	-13.29%	1.81B
FLEURY S.A.	-19.46%	1.56B
METROPOLIS HEALTHCARE LIMITED	+9.70%	1.13B
ADICON HOLDINGS LIMITED	-18.10%	1.04B

Medical & Diagnostic Laboratories